Terry Rosen
About Terry Rosen
Terry Rosen Chief Executive Officer
Terry Rosen serves as the Chief Executive Officer. With a significant breadth of experience, Terry's career has spanned various executive roles that have shaped his proficiency in steering company operations and strategy.
Terry Rosen Education and Career Expertise
Terry Rosen holds a PhD, providing him with a solid academic foundation that complements his extensive industry experience. His career in the biotechnology and pharmaceutical sectors spans over 30 years, focusing on drug discovery and development. His scientific and managerial expertise have been fundamental in his executive roles.
Terry Rosen Co-Founder of Arcus Biosciences
In 2015, Terry Rosen co-founded Arcus Biosciences, a company engaged in innovative drug discovery and development. His leadership at Arcus Biosciences leverages his deep industry expertise and entrepreneurial spirit to drive the company's mission.
Terry Rosen Previous Role as Flexus Biosciences CEO
Prior to founding Arcus Biosciences, Terry Rosen co-founded and served as the CEO of Flexus Biosciences. Under his leadership, Flexus Biosciences made significant strides in the field of biotechnology, showcasing his capacity for leading high-growth companies.
Terry Rosen Executive Positions at Amgen and Tularik
Terry Rosen has held executive positions at notable companies such as Amgen and Tularik. These roles have added to his comprehensive experience in the biotechnology and pharmaceutical sectors.
Terry Rosen Scientific and Management Roles at Pfizer and Abbott Laboratories
Terry's career also includes scientific and management positions at Pfizer and Abbott Laboratories. These roles further demonstrate his robust background in drug discovery and development, as well as operational management.
Terry Rosen Board Member at Salk Institute and California Life Sciences Association
Terry Rosen serves on the Board of Trustees at the Salk Institute, emphasizing his commitment to advancing scientific research. He is also on the board of the California Life Sciences Association, contributing his insights to the biotechnology community.